COVID-19 LESSONS LEARNED SERIES: RESPIRATORY THERAPY BEST PRACTICES FOR TREATMENT AND PATIENT CARE STRATEGIES

PRESENTER
RECORDING  

COVID-19 LESSONS LEARNED SERIES:
RESPIRATORY THERAPY BEST PRACTICES FOR TREATMENT AND PATIENT CARE STRATEGIES

PRESENTER

Vickie Carver-Parker, MBA, RRT, RPFT
University of Tennessee Medical Center
Knoxville, TN

SUMMARY

As healthcare systems continue struggle to deal with the impact of the COVID-19 pandemic and plan for an uncertain future, sweeping changes have occurred across the healthcare continuum. From ethical staffing considerations to specific patient care protocols, hospitals have adjusted multiple processes to deal with the immediate challenges posed by an influx of patients, while preparing for the “new normal” that lies ahead.

This webinar will focus on the experiences and lessons learned from the perspective of an academic medical respiratory therapy manager. At the conclusion of the presentation, participants will gain a better understanding of respiratory therapy patient care strategies, ventilator and treatment protocols, staff and patient safety recommendations, blood gas testing processes, and what key steps facilities should take to prepare for a potential second-wave of increased patient volume as we head into a respiratory season of unknown severity.

Learning objectives
  1. Identify key recommendations to ensure staff and patient safety while dealing with a potential overflow of ICU and ventilator-dependent patients
  2. Examine key changes to respiratory patient flows and staffing strategies, as well as ethical considerations to prepare for additional COVID-19 patient volume
  3. Discuss respiratory therapy treatment protocols, vent management and patient care best practices
  4. Examine resource utilization strategies and best practices
  5. Discuss what the “new normal” will look like in respiratory therapy treatment protocols and ICU departments

Continuing Education:
- One P.A.C.E.
® contact hour will be provided for this basic level session until April 28, 2021. Abbott is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.

- This session is approved for one Florida CE credit. Florida Board of Clinical Laboratory Personnel approved number: 50-12563

- This program has been approved for 1 CRCE Contact Hour by the American Association for Respiratory Care (AARC).

- This program has been approved by the American Association of Critical-Care Nurses (AACN), for 1.00 CERPs, Synergy CERP Category A, File Number 23275. Approval refers to recognition of continuing education only and does not imply AACN approval or endorsement of the content of this educational activity, or the products mentioned.

After viewing the recording, watch for the evaluation to appear in your browser. A link to your certificate will be emailed within two weeks of receipt of your completed evaluation.

LESSONS LEARNED FROM THE EPICENTER SERIES:
COVID-19 EMERGENCY MEDICINE BEST PRACTICES FROM THE FRONT
LINES OF A HOUSTON, TEXAS MEDICAL CENTER

 
PRESENTER
RECORDING  

LESSONS LEARNED FROM THE EPICENTER SERIES: COVID-19 EMERGENCY MEDICINE BEST PRACTICES FROM THE FRONT LINES OF A HOUSTON, TEXAS MEDICAL CENTER

PRESENTER

W. Frank Peacock, MD, FACEP, FACC, FESC
Professor, Vice Chair for Research
Henry JN Taub Department of Emergency Medicine
Baylor College of Medicine
Houston, Texas

SUMMARY

As healthcare systems continue to struggle to deal with the impact of the COVID-19 pandemic and plan for an uncertain future, sweeping changes have occurred across the healthcare continuum. From triage strategies to specific patient care protocols, hospitals have adjusted multiple processes to deal with the immediate challenges posed by an influx of patients, while preparing for the “new normal” that lies ahead.

This second installment of our COVID-19 webinar series will focus on the experiences and lessons learned from the perspective of a Houston, Texas emergency department physician. At the conclusion of the presentation, participants will gain a better understanding of emergency department triage strategies, treatment protocols, staff and patient safety recommendations, lab testing processes, and key steps facilities should take to prepare for a potential second-wave of increased patient volume as we head into a flu season of unknown severity.

Learning objectives
  1. Identify key recommendations to ensure staff and patient safety while dealing with a fragmented emergency department triage process
  2. Examine key changes to emergency department patient flows and co-horting strategies to prepare for additional COVID-19 patient volume
  3. Discuss emergency department treatment protocols and patient care best practices
  4. Examine resource utilization/PPE strategies and best practices
  5. Discuss what the “new normal” will look like in emergency department operations moving forward

Continuing Education:
- One P.A.C.E.
® contact hour will be provided for this basic level session until March 16, 2021. Abbott is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.

- This session is approved for one Florida CE credit. Florida Board of Clinical Laboratory Personnel approved number: 50-12563

- This program has been approved by the American Association of Critical-Care Nurses (AACN), for 1.00 CERPs, Synergy CERP Category A, File Number 23275. Approval refers to recognition of continuing education only and does not imply AACN approval or endorsement of the content of this educational activity, or the products mentioned.

After viewing the recording, watch for the evaluation to appear in your browser. A link to your certificate will be emailed within two weeks of receipt of your completed evaluation.

LESSONS LEARNED FROM THE EPICENTER SERIES:
COVID 19 BEST PRACTICES FROM A NEW YORK CITY HOSPITAL

 
PRESENTER
RECORDING  

LESSONS LEARNED FROM THE EPICENTER: COVID 19 BEST PRACTICES FROM A NEW YORK CITY HOSPITAL

PRESENTER

Wren Lester, PhD, CPHQ, CPXP, LSSBB
Chief Experience Officer

SUMMARY

As healthcare systems struggle to deal with the immediate impact of the COVID-19 pandemic and plan for an uncertain future, sweeping changes have occurred across the healthcare continuum. Hospitals have adjusted multiple processes and staffing strategies to deal with the immediate challenges posed by an influx of patients, while preparing for the “new normal” that lies ahead.

This webinar will be held in a discussion/interview format and will focus on the experiences and lessons learned from a hospital administrator at the center of the initial outbreak in New York City. At the conclusion of the presentation, participants will gain a better understanding of work force and patient safety recommendations, how hospitals must change patient-care processes, and key steps facilities should take to prepare for a potential second-wave of increased patient volume.

Learning objectives
  1. Identify strategies to improve the patient and family experience during COVID-19 isolation conditions
  2. Share strategies to maintain employee emotional well-being under unprecedented working conditions
  3. Examine key changes in patient workflows to meet surge demand while maintaining the overall patient experience
  4. Discuss procedural changes necessary to ensure staff and patient safety
  5. Outline planning strategies to help prepare for the “new normal”

Continuing Education:
- One P.A.C.E.
® contact hour will be provided for this basic level session until February 11, 2021. Abbott is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.

- This session is approved for one Florida CE credit. Florida Board of Clinical Laboratory Personnel approved number: 50-12563

After viewing the recording, watch for the evaluation to appear in your browser. A link to your certificate will be emailed within two weeks of receipt of your completed evaluation.

TROPONIN ESSENTIAL GUIDELINES: A PRACTICAL IMPLEMENTATION GUIDE

 
PRESENTER
RECORDING SLIDES

TROPONIN ESSENTIAL GUIDELINES: A PRACTICAL IMPLEMENTATION GUIDE

PRESENTER

Ruth Cantu, BSN, RN, AACC
Accreditation Product Development
ACC Accreditation Services


SUMMARY

This presentation will address the updates for Myocardial Infarction Guidelines which are important for clinicians and laboratorians as they provide valuable information on the new recommendations for serial Troponins as well as assay specifications. Information regarding Acute Coronary Syndromes (ACS) will provide a summary of statistics along with definitions of indicators under ACS. The methods for treating Myocardial Infarction (MI), also known as Acute MI or heart attack, including the acute phase in the ED as well as the diagnostic expectations for patients in observation status requiring accelerated serial marker protocols will also be discussed.

The presentation will include a brief over-view of the high-sensitive Troponin and discussion on Troponin Turn-Around-Time (TAT), testing methodologies and a review of quality practices to optimize patient care.
Learning objectives
  1. Review updates to the Myocardial Infarction (MI) Definition and other relevant guidelines
  2. Identify guideline-driven best practice recommendations on the use of biomarkers in the treatment of Acute Coronary Syndrome (ACS)
  3. Discuss Troponin turn-around-time (TTAT) and guideline recommendations for assay use in clinical practice
  4. Describe quality practices that optimize the care and outcomes of ACS patients

Continuing Education:
- One P.A.C.E.
® contact hour will be provided for this basic level session until August 21, 2019. Abbott is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.

- This session is approved for one Florida CE credit. Florida Board of Clinical Laboratory Personnel approved number: 50-12563

- This program has been approved by the American Association of Critical-Care Nurses (AACN) for 1.00 CERPs, Synergy CERP Category A, File number 22490

After viewing the recording, watch for the evaluation to appear in your browser. A link to your certificate will be emailed within two weeks of receipt of your completed evaluation.

PROCESS REDESIGN IN AMBULATORY EMERGENCY CARE
UTILISING POINT OF CARE TESTING

 
PRESENTER
RECORDING SLIDES

PROCESS REDESIGN IN AMBULATORY EMERGENCY CARE UTILISING
POINT OF CARE TESTING


PRESENTER


Phil Weihser BSc. PGCert. MSc.
James Paget University Hospital NHS Trust, UK

SUMMARY

Emergency departments in many countries are suffering from overcrowding and increased admission rates. This is due to numerous factors such as a rise in chronic disease, an ageing population and access to care.

Many healthcare systems are looking at models of care to help reduce the burden on acute services by decreasing the length of stay in hospital, and by reducing the number of unnecessary admissions.

This webinar highlights how a university hospital in the UK has tackled the problem, by implementing a 7-day Ambulatory Emergency Care service (AEC). The speaker will highlight the clinical, financial and operational benefits achieved through the novel use of point of care testing, evidence-based service redesign, condition specific pathways, and access to senior clinical  decision makers.
Learning objectives
  1. Discuss how to redesign service in acute and emergency medicine
  2. Demonstrate how point-of-care testing pathways can help drive new models of care
  3. Examine the potential improvement metrics including reduction in hospital admissions and length of stay



This event is produced by Whitehat Communications and sponsored by Abbott Point of Care.

Certificate of attendance:
You can receive a certificate of attendance for viewing the recording until January 12, 2019. After viewing the recording, watch for the evaluation to appear in your browser. A link to your certificate will be emailed within two weeks of receipt of your completed evaluation.
   
 

ACT TESTING

   
PRESENTER
RECORDING SLIDES

ACT TESTING:
WHEN THERE'S NO ROOM FOR DOUBT


PRESENTER


Dr. Florian Falter, MD
Royal Papworth Hospital, UK

SUMMARY

ACT tests with some traditional analysers can lead to highly variable results, raising doubt about the accuracy of critical results1. Additionally, some second generation systems have diverged from using the traditional standard Celite and Kaolin activator biochemistry.

In this educational webinar, Dr.Falter will introduce different ACT technologies and discuss best use of modern ACT testing technology. He will also discuss the clinical impact that different ACT analysis methods can have, along with key laboratory aspects of coagulation testing during cardiac surgery.

 1 Reference: Ojito JW et al. J Extra Corpor Technol 2012;44:15-20
Learning objectives
  1. Examine laboratory requirements of test accuracy and reliability
  2. Differentiate between laboratory and point of care approach to intra-operative coagulation testing during cardiac surgery
  3. Identify the various methods of assessing heparin activity
  4. Assess the technological differences between different methods of measuring the Activated Clotting Time (ACT)
  5. Evaluate the clinical impact of the different ACT technologies

Continuing Education:
One P.A.C.E.® contact hour will be provided for this basic level session until December 4, 2018. Whitehat Communications is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program.
This session is approved for one Florida CE credit. Florida Board of Clinical Laboratory Personnel approved number: 50-12563

This event is produced by Whitehat Communications and sponsored by Abbott Point of Care.

   
 
 

TROPONIN ESSENTIALS

PRESENTER
RECORDING SLIDES

TROPONIN ESSENTIALS:
IMPLEMENTING THE GUIDELINES

PRESENTER
Ruth Cantu, BSN, RN, AACC
Program Manager, ACC Accreditation Services

Summary
The detection of a rise and/or fall of cardiac troponin plays a key role in identification of patients suspected of having an Acute Coronary Syndrome (ACS) and earlier diagnosis of myocardial infarction. However, individuals with non-ACS conditions can also have elevated cardiac troponin and many symptoms associated with non-ACS conditions may overlap with symptoms of ACS1. This presents a diagnostic challenge to the clinician and often requires an extended evaluation before the clinician can make an accurate diagnosis, which can impact efficiency and quality of care. This webinar will share an evidence-based approach to diagnosis and treatment of the ACS patient, with a focus on the current guidelines for troponin testing.
Learning objectives
  1. Identify guideline-driven best practice recommendations on the use of biomarkers in the treatment of Acute Coronary Syndrome (ACS)
  2. Review updates to the Myocardial Infarction (MI) Definition and Non-ST elevation Acute Coronary Syndromes (NSTE-ACS) guidelines
  3. Discuss troponin turn-around-time recommendations and documentation requirements
  4. Share quality practices that optimize the care and outcomes of ACS patients
Reference: 1. Third Universal Definition of Myocardial Infarction (MI), Kristian Thygesen, Joseph S. Alpert, Allan S. Jaffe, Maarten L. Simoons, Bernard R. Chaitman and Harvey D. White, Circulation 2012;126:2020-2035 
www.scpc.org/resources/PDFs/ThirdUniversalDefinitionofMyocardialInfarction_CIRC2012.pdf
Heart image w logos